ArticleRSC advances2026
Expedient synthesis of poly-aryl substituted allenylsilanes
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Allenylsilanes serve as important and versatile intermediates in organic synthesis, finding widespread applications in medicinal chemistry and materials science. A mild and regioselective silylation of 1,3-diaryl propargyl carbonates using palladium and copper as co-catalysts is reported herein. Under this method various poly-aryl substituted allenylsilanes were obtained in mono-regioselectivities and excellent yields. Compared with the existing single-metal catalytic systems, this Pd/Cu cooperative activation mode exhibits superior substrate adaptability and reaction efficiency. This work not only enriches the synthetic methodology for allenylsilanes but also provides a new avenue for the synthesis of poly-aryl substituted allene derivatives.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.